Insights On CONTRACT PHARMA MANUFACTURING

  1. Fast-Track Innovation, Address CMC Challenges In Expedited Pathways 1/26/2026

    Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

  2. GMP Clinical Storage Solutions for Today's Complex Trials 1/26/2026

    How material traits, dosing approaches, and equipment design affect capsule‑filling accuracy and efficiency, giving teams insight to improve dose precision and support small‑scale manufacturing.

  3. Lyo‑Modelling For Risk Reduction And Process Insights 1/26/2026

    Use lyophilization modelling to optimize freeze‑drying, boost product quality, and lower commercialization risks through predictive insights, robustness analysis, and deeper process understanding.

  4. Covalent Warhead Reactivity: A New Look At GSH Reactivity Assays 1/26/2026

    Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.

  5. Mirror, Mirror Makes RNA-targeted Discovery Smarter 1/26/2026

    Examine a mirror‑image screening approach that eliminates DNA:RNA hybridization, revealing true binders and unlocking clearer, more productive DEL results for challenging RNA targets.

  6. Discover Our DNA-Encoded Library (DEL) Technology 1/26/2026

    Discover how DNA barcoding enables rapid screening of vast chemical space in early drug discovery, as well as how DEL platforms test billions of compounds efficiently.

  7. Advancing Chronic Care Through GLP‑1 Innovation 1/23/2026

    GLP‑1 therapies are changing injectable care and driving rapid progress in delivery and manufacturing. See how patient needs, emerging tech, and regulations are reshaping chronic treatment.

  8. How Reshoring, GLP-1s, And Supply Chain Security Are Transforming CDMOs 1/23/2026

    Explore how reshoring, GLP-1 capacity demands, and integrated U.S.-based manufacturing models are reshaping CDMO partnerships in a rapidly evolving pharmaceutical market.

  9. Strategic Hiring For Scalable Success 1/22/2026

    Discover how a people-first talent strategy, purpose-driven culture, and cross-functional collaboration come together to support scalable growth and operational excellence in commercial manufacturing.

  10. Operational Success By Strategic Investment 1/22/2026

    Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.